Orexo US Blog Contact EN About Us Key Therapeutic Areas Pharmaceuticals Digital Therapies Sustainability Investors Media OREXO ABOUT US Orexo in brief Orexo develops improved pharmaceuticals and digital therapies addressing unmet needs within the growing space of mental illness and substance use disorders. The products are commercialized by Orexo in the US or via partners worldwide. The main market today is the American market for buprenorphine/naloxone products, where Orexo commercializes its lead product ZUBSOLV® for treatment of opioid use disorder. Total net sales for 2020 amounted to SEK 664 million and the number of employees was 138. Developed four commercial pharmaceutical products with worldwide approval Addresses unmet need within the growing space of mental illness and addiction disorders Broad product portfolio and development pipeline of traditional pharma products and digital therapies Strategic focus on portfolio expansion through development and licensing and M&A Strong financial position enables investment in future growth Own commercial plattform in the US Since 2013, Orexo has been commercializing its key product ZUBSOLV®, for treatment of opioid dependence, in the US. The company's own sales force covers large parts of the country and in 2020 an important milestone was reached when ZUBSOLV´S total gross sales, since start, exceeded USD 1 billion. READ MORE ABOUT OUR LEAD PRODUCT The new future starts to take shape One of the most important objectives has been to broaden the product portfolio to capitalize the US commercial organization. In 2019, a collaboration was initiated with GAIA, a world leader in the development of digital therapeutics, and in 2020, Orexo's product portfolio grew with three digital therapies. READ MORE Thanks and welcome back! ©2021 Orexo AB (publ.) – All rights reserved Contact | Dictionary & Definitions | Privacy Policy | Legal notice | Cookie policy

Orexo US Blog Contact EN About Us Key Therapeutic Areas Pharmaceuticals Digital Therapies Sustainability Investors Media OREXO INVESTORS FINANCIAL CALENDAR & EVENTS Financial calendar & events Financial calendar & events Past Events Stora Aktiedagen Stockholm, Sweden NOVEMBER 29, 2021 Pharma Network Breakfast Seminar Pharma & Digital Health DECEMBER 7, 2021 JP Morgan 40th Annual Healthcare Conference JANUARY 10, 2022 DTx Global 2022 JANUARY 18, 2022 Full Year Report incl. Q4, 2021 JANUARY 27, 2022 Thanks and welcome back! ©2021 Orexo AB (publ.) – All rights reserved Contact | Dictionary & Definitions | Privacy Policy | Legal notice | Cookie policy